EDITOR’S NOTE: Global Perspectives is a live event series in which CNN brings together international leaders, top executives, entrepreneurs, and innovators for a day of compelling discussions on redefining global leadership across trade, finance, tech, luxury, culture and sustainability. This next event will be held Oct. 14, in Bangkok.
Advances in medicine, from genomics to biomarkers to artificial intelligence, have provided us with predictive tools that allow us to peer into our medical future in ways that once seemed inconceivable.
Today, we can find out whether we are predisposed to an array of diseases. Almost every baby in America gets their heels pricked shortly after birth, a blood sample is collected that screens them for serious treatable conditions like cystic fibrosis, sickle cell anemia and the rare metabolic disorder phenylketonuria, or PKU.
But today, through genomic screening, parents can choose to learn about hundreds of other conditions that might strike their babies one day, including learning about a disease that could otherwise go undetected.
Dr. Robert C. Green is one of the world’s leading experts of genomic screening, saying it is key to preventing millions of deaths from preventable disease. He is a physician-scientist and professor at Harvard Medical School who studies and treats inherited and genetic disorders.
